Al‐Karagholi, M. A., Hansen, J. M., Abou‐Kassem, D., Hansted, A. K., Ubhayasekera, K., Bergquist, J., . . . Ashina, M. (2021). Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers. Pharmacol Res Perspect.
Chicago Style CitationAl‐Karagholi, Mohammad Al‐Mahdi, Jakob Møller Hansen, Dalia Abou‐Kassem, Anna Koldbro Hansted, Kumari Ubhayasekera, Jonas Bergquist, László Vécsei, Inger Jansen‐Olesen, and Messoud Ashina. "Phase 1 Study to Access Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Kynurenine in Healthy Volunteers." Pharmacol Res Perspect 2021.
MLA CitationAl‐Karagholi, Mohammad Al‐Mahdi, et al. "Phase 1 Study to Access Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Kynurenine in Healthy Volunteers." Pharmacol Res Perspect 2021.